Production (Stage)
Beam Therapeutics Inc.
BEAM
$16.83
-$0.41-2.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -109.27M | -90.35M | -96.67M | -91.05M | -98.67M |
| Total Depreciation and Amortization | 5.53M | 5.44M | 5.48M | 5.58M | 5.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.33M | 29.30M | 28.67M | 28.38M | 31.45M |
| Change in Net Operating Assets | -25.47M | -20.75M | -25.60M | -25.91M | -37.96M |
| Cash from Operations | -103.88M | -76.37M | -88.13M | -83.01M | -99.75M |
| Capital Expenditure | -3.07M | -2.97M | -1.58M | -1.96M | -2.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.02M | 129.25M | 26.28M | 89.45M | -51.03M |
| Cash from Investing | -125.09M | 126.28M | 24.70M | 87.49M | -53.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -201.00K | -107.00K | -177.00K |
| Issuance of Common Stock | 473.38M | 3.44M | 1.46M | 240.00K | 3.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 473.38M | 3.44M | 1.26M | 133.00K | 2.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.41M | 53.36M | -62.17M | 4.62M | -150.31M |